Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Flechtner

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
British Journal of Cancer|April 19, 2014
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trialD E Ediebah, C Coens, E Zikos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patientsJ Maringwa, C Quinten, M King, et al.
The Lancet. Oncology|October 16, 2009
Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trialNatacha Heutte, Henning H Flechtner, Nicolas Mounier, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
British Journal of Cancer|April 19, 2014
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trialD E Ediebah, C Coens, E Zikos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patientsJ Maringwa, C Quinten, M King, et al.
The Lancet. Oncology|October 16, 2009
Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trialNatacha Heutte, Henning H Flechtner, Nicolas Mounier, et al.
Pageof 4